Irritable bowel syndrome: physicians' awareness and patients' experience. by Olafsdottir, Linda Bjork et al.
Linda Bjork Olafsdottir, Hallgrímur Gudjonsson, Heidur Hrund Jonsdottir, Jon Steinar Jonsson, 
Einar Bjornsson, Bjarni Thjodleifsson
Irritable bowel syndrome: Physicians' awareness and 
patients' experience
Linda Bjork Olafsdottir, Hallgrímur Gudjonsson, Einar 
Bjornsson, Bjarni Thjodleifsson, Department of Gastroenter-
ology, Landspitali, Faculty of Medicine, University of Iceland, 
Hringbraut, 101 Reykjavik, Iceland
Heidur Hrund Jonsdottir, The Social Science Research Institute, 
University of Iceland, Saemundargotu 2, 101 Reykjavik, Iceland
Jon Steinar Jonsson, Gardabaer Health Centre, Gardatorgi 7, 
210 Gardabae, Iceland
Author contributions: Olafsdottir LB, Thjodleifsson B, Jons-
son JS and Gudjosnsson H designed the research; Olafsdottir LB 
performed the research; Olafsdottir LB and Jonsdottir HH ana-
lyzed the data; and Olafsdottir LB, Bjornsson E, Jonsson JS and 
Thjodleifsson B wrote the paper.
Supported by In part by the Medical Research Fund of the Na-
tional Hospital of Iceland; the Medical Research Fund of Wyeth, 
Iceland; Actavis, Iceland; AstraZeneca, Iceland; GlaxoSmith-
Kline, Iceland; and the Icelandic College of Family Physicians
Correspondence to: Linda Bjork Olafsdottir, PhD, MSc 
Pharm, MBA, Department of Gastroenterology, Landspitali, Fac-
ulty of Medicine, University of Iceland, Hringbraut, 101 Reykja-
vik, Iceland. linda04@ru.is
Telephone: +354-8966664  Fax: +354-5200801
Received: May 12, 2011      Revised: May 11, 2012 
Accepted: June 8, 2012
Published online: July 28, 2012 
Abstract
AIM: To study if and how physicians use the irritable 
bowel syndrome (IBS) diagnostic criteria and to assess 
treatment strategies in IBS patients.
METHODS: A questionnaire was sent to 191 physi-
cians regarding IBS criteria, diagnostic methods and 
treatment. Furthermore, 94 patients who were diag-
nosed with IBS underwent telephone interview.
RESULTS: A total of 80/191 (41.9%) physicians re-
sponded to the survey. Overall, 13 patients were diag-
nosed monthly with IBS by specialists in gastroenterolo-
gy (SGs) and 2.5 patients by general practitioners (GPs). 
All the SGs knew of the criteria to diagnose IBS, as did 
46/70 (65.7%) GPs. Seventy-nine percent used the pa-
tient’s history, 38% used a physical examination, and 
38% exclusion of other diseases to diagnose IBS. Only 
18/80 (22.5%) physicians used specific IBS criteria. Of 
the patients interviewed, 59/94 (62.8%) knew they had 
experienced IBS. Two out of five patients knew IBS and 
had seen a physician because of IBS symptoms. Half of 
those received a diagnosis of IBS. A total of 13% were 
satisfied with treatment. IBS affected daily activities in 
43% of cases. 
CONCLUSION: Half of the patients with IBS who con-
sulted a physician received a diagnosis. Awareness and 
knowledge of diagnostic criteria for IBS differ between 
SGs and GPs. 
© 2012 Baishideng. All rights reserved.
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INTRODUCTION
Irritable bowel syndrome (IBS) is a common functional 
gastrointestinal disorder. The prevalence of  IBS is es-
timated to range from 3% to 28% depending on the 
country studied[1-4]. The prevalence of  IBS in the western 
countries is estimated to be 10%-15%[2]. However, as-
certaining prevalence is based on various approaches in 
studies using different diagnostic criteria. 
The criteria that have been used to identify IBS pa-
tients are the Manning criteria[5], Rome Ⅰ[6], Rome Ⅱ[7] 
and the most recent Rome Ⅲ criteria[8,9]. The Rome crite-
ria are more refined than the Manning criteria and include 
the duration of  symptoms as part of  the definition of  
IBS[10]. Studies have also shown that the Manning criteria 
are relatively sensitive but lack specificity[11] (Table 1).
It has been questioned whether the Rome criteria are 
sensitive enough to diagnose patients in general practice. 
The current lack of  interest in these criteria, especially 
among general practitioners (GPs), is unlikely to change 
unless they can be considerably improved[12]. The chal-
lenges and uncertainties for diagnosis of  IBS have been 
listed as follows[13,14]: (1) there is currently no consistent 
biological marker of  IBS, leaving clinicians to rely on 
patient symptoms alone to make the diagnosis; (2) symp-
toms of  IBS are often difficult to quantify objectively; (3) 
symptoms can vary among individuals with IBS; and (4) 
many organic conditions can masquerade as IBS.
With these uncertainties, many physicians approach 
IBS as a diagnosis of  exclusion[14]. A recent study con-
cluded that: (1) the best practise diagnostic guidelines 
have not been uniformly adopted in IBS, particularly 
among primary care providers; (2) most community pro-
viders believe IBS is a diagnosis of  exclusion (this belief  
is associated with increased diagnostic resource use); and 
(3) despite the dissemination of  guidelines regarding di-
agnostic testing in IBS, there remains extreme variation in 
beliefs among both experts and non-experts[14].
 Patients diagnosed with IBS exhibit a higher use of  
outpatient visits, inpatient stays, outpatient prescriptions, 
and number of  hospitalizations than those not diagnosed 
with IBS[15-17]. A recent study showed that knowledge 
and use of  the Rome criteria or their positive predictive 
values for IBS did not correlate with reduced use of  di-
agnostic tests[18]. The cost for outpatient visits, drugs and 
diagnostic testing has been shown to be 51% higher for 
IBS patients than for others[15-17]. IBS patients have been 
shown to lose time from work more often than others 
and are less productive while at work[19]. This may reflect 
the morbidity in this relatively benign disorder, although 
up to 70% of  IBS patients in the United States do not 
consult a health care provider regarding their symp-
toms[20]. IBS patients are often reluctant to consult a phy-
sician, often because they think their symptoms do not 
warrant a visit to a physician or are afraid that they have 
a serious life-threatening illness[2,19]. United States fam-
ily practitioners have problems with IBS patients, which 
include difficulties in satisfying patients and difficulties in 
making a strategy decision and finding the time required, 
and their lack of  knowledge could interfere with patient 
care[21]. No specific treatment options for IBS are avail-
able. In clinical practice, the decision to treat is up to the 
discretion of  the physician[19]. While some physicians 
recommend lifestyle modification or trials with over-the-
counter products, others recommend antispasmodics and 
antidepressants.
In our study, we aimed to analyze IBS from the physi-
cians’ and patients’ point of  view. The specific aims of  
this study were: First, physician study, to assess if  and 
how physicians [GPs and specialists in gastroenterology 
(SGs)]: (1) use the diagnostic criteria to identify IBS; (2) 
diagnose patients with IBS, and which symptoms of  IBS 
they identify; and (3) which treatment they recommend; 
and Second, patient study, to assess how patients with 
IBS are diagnosed and treated by physicians, as well as 
studying the ideas that patients have about IBS. The re-
sults of  a parallel study based on the same database but 
focusing on functional dyspepsia, stability of  IBS and 
heartburn have been published[22-24]. 
MATERIALS AND METHODS
Patient study
Participants and setting: In 1996, an epidemiological 
study of  gastrointestinal diseases was performed in Ice-
land[25] among 2000 inhabitants aged 18-75 years. The indi-
viduals were randomly selected from the National Registry. 
Equal distribution of  sex and age was secured in each age 
group. In 2006, we attempted to contact all the individu-
als from 1996, as well as adding 300 new individuals in the 
18-27 years age group, who were also randomly selected 
from the National Registry of  Iceland. A questionnaire 
was mailed to individuals at baseline and the study ques-
tionnaire and an explanatory letter mailed to all eligible in-
dividuals. Reminder letters were mailed at 2 wk, 4 wk and 7 
wk, using the Total Method of  Dillman[26]. Individuals who 
indicated at any point that they did not want to participate 
in the study were not contacted further.
Questionnaire: The Bowel Disease Questionnaire (BDQ)[27,28] 
was translated from English into Icelandic and modified 
for this study. The questionnaire was translated by two gas-
troenterologists and a pharmacist. A specialist in the Ice-
landic language at the University of  Iceland made linguistic 
modifications. The questionnaire was piloted within a small 
group of  IBS patients diagnosed by a gastroenterologist. 
The questionnaire was designed as a self-report instrument 
to measure symptoms experienced over the previous year 
and to collect the participants’ past medical history[29]. 
The Icelandic version of  the BDQ questionnaire ad-
dressed 47 gastrointestinal symptoms and 32 items that 
measured past illness, health care use, and sociodemo-
graphic and psychosomatic symptoms, together with a 
valid measure of  non-gastrointestinal somatic complaints, 
the Somatic Symptom Checklist (SSC)[30]. The SSC con-
sisted of  12 non-gastrointestinal and five gastrointestinal 
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symptoms or illnesses. Individuals were instructed to 
indicate, on a 5-point scale, how often each symptom 
appeared and how bothersome it was. There were only a 
few changes in the 2006 questionnaire, which addressed 
51 gastrointestinal symptoms and 33 items that measured 
past illness, health care use, and sociodemographic and 
psychosomatic symptoms. The 2006 questionnaire fur-
thermore addressed 17 items to identify heartburn and 
symptoms related to heartburn. 
Telephone survey: In the questionnaire, patients were 
asked to write down their telephone number and give 
their permission to participate in a telephone survey. 
Subjects who were diagnosed with IBS based on the 
Manning criteria and/or the Rome Ⅲ criteria and had 
written down their telephone number were called and in-
terviewed. 
Physician study
In Iceland (population approximately 300 000), there are 
177 physicians working in general practice and 17 SGs 
(three physicians who were involved in carrying out this 
study were excluded). A questionnaire was sent to these 
191 physicians regarding awareness and application of  
the three sets of  criteria used to diagnose IBS (Table 1), 
as well as diagnostic methods and treatment of  this dis-
order. We assessed the knowledge of  validated symptom-
based criteria for IBS. 
Statistical analysis
Tables were constructed for frequency and percentage. 
Categorical data were analyzed using the χ 2 test. The 
type Ⅰ error protection rate was set at 0.05. The exact P 
values are listed in the tables and text. All the research 
data were imported into SPSS software.
Ethics
The National Bioethics Committee of  Iceland and The 
Icelandic Data Protection Authority (Personuvernd) gave 
their permission for the research.
RESULTS
Patient study 
A total of  94 patients underwent telephone interview 
(29.8% male, 70.2% female) with a mean age of  47 years. 
All these had IBS according to the Manning criteria and 
56.0% according to the Rome Ⅲ criteria (the Rome Ⅲ 
criteria being more refined and stricter than the Manning 
criteria). When patients were asked if  they had experi-
enced IBS (self-assessed), 62.8% reported yes and 21.3% 
said they had received an IBS diagnosis from a physician; 
60% of  these had a Rome-Ⅲ-based diagnosis, and 100% 
had a Manning-based diagnosis. 
Table 2 shows the awareness of  IBS. Two out of  five 
patients had heard of  IBS and the same number had 
seen a physician because of  IBS symptoms, but only half  
of  those had received a diagnosis of  IBS. Only 12/94 
(12.8%) IBS patients were satisfied with the treatment 
they had been given. IBS did affect daily activities in ap-
proximately 43% of  the cases (Table 2). One third of  the 
IBS patients thought they would be cured of  IBS but a 
similar proportion thought they would always suffer from 
IBS (Table 2). IBS patients were found to use more non-
traditional medication than prescribed drugs. More than 
half  of  patients believed that dietary modification was 
important for treatment of  IBS (Table 2).
Three out of  five IBS patients were diagnosed by a 
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Table 1  Manning, Rome Ⅰ, Ⅱ and Ⅲ criteria for irritable 
bowel syndrome[5-7,9]
Manning
Pain eased after BM
Looser stools at onset of pain
More frequent BM at onset of pain
Abdominal distension
Mucus throughout rectum
Feeling of incomplete emptying
Rome Ⅰ criteria
   3 mo or more of continuous or recurrent symptoms
   Abdominal pain or discomfort
   Relieved with defecation; and/or 
   Associated with a change in frequency of stool; and/or
   Associated with a change in consistency of stool; and
   Two or more of the following, at least 25% of occasions or days
   Altered stool frequency (> 3 BMs/d or < 3/wk)
   Altered stool form (lumpy/hard or loose/watery stool),
   Altered stool passage (straining, urgency, tenesmus)
   Passage of mucus
   Bloating or feeling of abdominal distension
Rome Ⅱ criteria
   At least 12 wk (which need not be consecutive)
   In the preceding 12 mo, of abdominal discomfort or pain that has two 
out of three features
   Relieved with defecation; and/or
   Onset associated with a change in frequency of stool, and/or
   Onset associated with a change in form (appearance) of stool
Rome Ⅲ criteria
   Recurrent abdominal pain or discomfort at least 3 d/mo 
   In the last 3 mo association with two or more of the following:
   Improvement with defecation
   Onset associated with a change in frequency of stool
   Onset associated with a change in form (appearance) of stool
BM: Bowel movement. 
Table 2  Awareness of the disorder, diagnosis and treatment 
in interviewer-diagnosed patients  n  (%)
All patients (n  = 94)
Diagnosed with IBS 20 (22.2)
Knowledge of IBS 37 (39.4)
Seen a physician because of IBS symptoms 37 (39.4)
Satisfied with treatment for IBS 12 (12.8)
IBS affects daily activities 40 (42.6)
Think they will be cured of IBS 29 (30.9)
Think they will always suffer from IBS 27 (28.7)
Takes medication for IBS 11 (11.7)
Uses untraditional medication 15 (16.0)
Thinks dietary modification is important for 
the treatment of IBS
52 (55.3)
IBS: Irritable bowel syndrome.
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is therefore very important. In recent years, the develop-
ment of  diagnostic criteria for IBS has been ongoing, 
leading to the recent introduction of  the Rome Ⅲ crite-
ria. There is no doubt that diagnostic criteria constitute a 
useful and important tool to help physicians make a posi-
tive diagnosis of  IBS without resorting simply to exclud-
ing other diseases. This study has revealed the proportion 
of  Icelandic physicians in two fields of  medicine who are 
aware of  the criteria for diagnosing the disease. The study 
has addressed not only the question of  how informed 
physicians are of  the criteria for diagnosing IBS, but also 
the importance of  consensus about the diagnosis of  the 
disease. This study has also addressed the IBS patients’ 
perspective, how many sought physicians, and how they 
gastroenterologist and two out of  five by a GP. Most 
IBS patients reported abdominal pain (73.7%), bloating 
(21.1%), constipation (5.3%) and diarrhea (10.5%) as the 
symptom that led to the diagnosis. More than half  (57.9%) 
of  the IBS patients who received management for their 
IBS symptoms were satisfied.
Physician study
An anonymous questionnaire was sent to a total of  191 
physicians in Iceland in the fields of  primary care, or to 
SGs (excluding three physicians involved in carrying out 
this study). A total of  80 physicians (41.9%) replied (83% 
male, 17% female) and completed the questionnaire. Of  
those who answered, 70/175 were GPs and 9/15 were 
SGs. 
On average, 13 patients were estimated to be diagnosed 
with IBS monthly by SGs and 2.5 by GPs. Physicians re-
ported how they diagnosed patients with IBS (Table 3). 
Two thirds of  all the physicians knew that special diagnos-
tic criteria exist for defining and diagnosing IBS (Figure 1). 
When physicians were asked if  they knew of  the IBS 
diagnostic criteria, 71% said yes (64% of  GPs, 100% of  
SGs). Despite the fact that 64% of  GPs claimed they 
knew that diagnostic criteria existed, only 10% had heard 
of  the Manning criteria, 27% of  Rome Ⅰ, and 17% of  
Rome Ⅱ (Figure 1).
Physicians stated that abnormal bowel movements 
such as diarrhea and constipation, abdominal pain and 
bloating were the most commonly reported symptoms of  
IBS (Table 4).
Physicians reported in most cases that they would give 
advice on diet and education about IBS as a treatment 
for IBS symptoms. Both GPs and SGs gave their patients 
mebeverine in most cases. Psyllium was frequently used 
by SGs and chlordiazepoxide, and clidinium was in some 
cases used by both GPs and SGs (Table 5).
DISCUSSION
Most physicians have used the method of  exclusion when 
diagnosing patients with IBS. Most community provid-
ers also believe IBS is a diagnosis of  exclusion rather 
than using positive criteria to support the diagnosis[14]. 
This approach-or lack of  one-has therefore been time 
consuming and costly for the health care system. The 
importance of  a precise diagnostic tool to diagnose IBS 
Table 3  Diagnosis of patients with irritable bowel syndrome (%)
All patients SG GP
n  = 801 n  = 9 n  = 70
Patients history 79 78 80
Physical examination 38 22 41
Exclusion of other diseases 38 44 35
IBS criteria 22 33 19
Gastrointestinal endoscopy   7 22   6
1One physician did not list his profession; IBS: Irritable bowel syndrome; 











Manning                    Rome I                    Rome Ⅱ
Figure 1  Number of physicians knowing about each set of diagnostic cri-
teria. SG: Specialists in gastroenterology; GP: General practitioners.
Table 4  Most common irritable bowel syndrome symptoms (%)
GPs SGs
Abnormal bowel movements 61 100
Abdominal pain 86   67
Bloating 20   56
Gas   9   11
Passage of mucus   5     0
Incomplete evacuation with defecation   5   11
SG: Specialists in gastroenterology; GP: General practitioners.
Table 5  Treatment of irritable bowel syndrome (%)
GPs SGs
Medication
   Mebeverine 89 86
   Husk 31 43
   Chlordiazepoxide and clidinium 29 14
   Antidepressants   7 14
   Other medicines   9 14
Lifestyle
   Food 98 86
   Relaxation 14 14
   Exercise 16 14
Education about IBS 90 86
Do not know/something else 27 14
IBS: Irritable bowel syndrome; SG: Specialists in gastroenterology; GP: 
General practitioners.
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experienced the disease.
According to the results of  this study, most IBS pa-
tients were seen by GPs, and this is most likely also the 
case in other countries, underlining the importance of  
awareness and knowledge of  IBS on the part of  the GPs. 
Although 64% of  all GPs reported that they were aware 
of  the fact that special criteria to identify IBS existed, 
most of  them (81%) did not know the criteria and there-
fore did not rely on them in practice. Most of  them seem 
to make a positive diagnosis of  IBS without the use of  
endoscopy. A United States study showed that only 30% 
of  family practitioners knew that the Manning, Rome 
and Rome Ⅱ criteria are used to diagnose IBS, which is 
in line with the results of  the current study[21]. GPs are 
more likely than hospital specialists to perceive functional 
gastrointestinal disorders as having a psychological basis, 
are far less likely to be familiar with diagnostic criteria, 
and are more likely to use other methods to make such 
diagnoses[31]. However, physicians are aware of  and use 
the most common IBS symptoms such as abnormal 
bowel movements, abdominal pain and bloating in their 
diagnostic approach, and these were the most common 
symptoms IBS subjects in the present study. 
In the current study, physicians reported in most cases 
that they gave advice on diet and education on IBS as a 
treatment of  IBS symptoms; this finding underlines the 
importance of  providing reliable and useful information 
on IBS to patients, as well as the fact that there are no 
specific treatment options for IBS that are useful for all 
patients.
It is of  interest that among interviewer-diagnosed IBS 
patients, only one out of  five was diagnosed with IBS, 
even though more than half  of  the IBS patients saw a 
physician because of  their symptoms. These results were 
irrespective of  whether the patients fulfilled the Manning 
or Rome Ⅲ criteria for IBS. This was also interesting 
because the majority of  IBS patients reported that IBS 
affected daily activities. This emphasises the question 
of  whether IBS patients reveal to the physicians the low 
quality of  life caused by IBS. It is also conceivable that 
physicians do not recognize IBS as a disorder that leads 
to impaired quality of  life. The absence of  positive diag-
nosis of  IBS might lead to lack of  relevant treatment for 
specific symptoms of  IBS such as abdominal pain. There 
is a need for a simple, practical and reliable diagnostic 
tool to be used in everyday clinical practice to diagnose 
IBS more accurately; a tool that will encourage physicians 
to be able to make a reliable diagnosis and to provide ef-
fective treatment[32,33]. 
The limitation of  this study was the relatively low re-
sponse rate in the physician study, which raises the ques-
tion as to whether the level of  awareness and knowledge 
of  diagnostic criteria might be even lower than the result 
obtained. The strengths of  the study, however, were that 
all physicians in Iceland in the relevant fields of  general 
practice and gastroenterology were invited to participate, 
and the fact that all IBS patients who were contacted by 
telephone participated in the survey.
In conclusion, in this study, only half  of  the IBS pa-
tients who saw a physician received a diagnosis of  IBS. 
Knowledge of  IBS is limited among IBS patients. This 
study suggests that few physicians use IBS criteria and 
that awareness and knowledge of  diagnostic criteria for 
IBS differed between SGs and GPs. One out of  four 
physicians used a diagnosis of  exclusion. 
More widespread knowledge and use of  the diagnos-
tic criteria among physicians can be expected to support 
a more accurate diagnosis of  IBS.
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